Yahoo · Sep 18, 2026
IBD Stock Of The Day Eyes Buy Points As Investors Dig Into Its Pipeline
Incyte is Friday's IBD Stock Of The Day. Shares are testing a trendline within a base. That would offer an early entry into the biotech..
NYSE · INCY
Incyte Corporation
Healthcare · Biotechnology
$125.31
Down-$2.31 (-1.81%)
Updated Sep 20, 2026, 8:17 AM
SID Score
7.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 18.86B
- P/E ratio
- 15.82
- Dividend yield
- 0.00%
- 52-week range
- $89.25 – $132.60
- Volume
- 3.7M
- Avg. volume
- 2.2M
Price performance
INCY price history
1M range · 19 trading sessions · Daily adjusted prices
INCY closed at $125.31 after 19 trading sessions, down 2.09% for the selected period.
- Last close
- $125.31
- Period change
- -2.09%
- Period low
- $121.47
- Period high
- $129.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $127.85 | $128.72 | $125.23 | $125.31 | 3.7M |
| Sep 17, 2026 | $125.74 | $127.74 | $125.10 | $127.62 | 1.47M |
| Sep 16, 2026 | $121.48 | $124.96 | $121.48 | $124.75 | 1.35M |
| Sep 15, 2026 | $121.58 | $122.19 | $119.97 | $121.74 | 1.56M |
| Sep 14, 2026 | $122.48 | $123.345 | $121.28 | $122.19 | 1.46M |
| Sep 11, 2026 | $124.35 | $124.35 | $121.42 | $121.47 | 1.43M |
| Sep 10, 2026 | $125.09 | $126.31 | $122.58 | $123.28 | 1.46M |
| Sep 9, 2026 | $125.66 | $127.72 | $123.57 | $126.01 | 1.3M |
| Sep 8, 2026 | $124.105 | $126.40 | $122.222 | $124.40 | 1.28M |
| Sep 4, 2026 | $126.46 | $128.08 | $126.04 | $126.75 | 1.04M |
| Sep 3, 2026 | $129.67 | $130.00 | $126.2001 | $128.00 | 910.23K |
| Sep 2, 2026 | $126.43 | $129.56 | $125.89 | $128.83 | 2.32M |
| Sep 1, 2026 | $124.61 | $125.1392 | $122.50 | $125.01 | 1.19M |
| Aug 31, 2026 | $122.66 | $124.00 | $121.61 | $123.22 | 1.48M |
| Aug 28, 2026 | $127.74 | $127.74 | $123.08 | $124.37 | 1.22M |
| Aug 27, 2026 | $128.13 | $128.20 | $126.06 | $127.74 | 700.68K |
| Aug 26, 2026 | $129.18 | $129.535 | $127.7701 | $128.12 | 800.28K |
| Aug 25, 2026 | $128.975 | $130.80 | $127.50 | $129.72 | 1.16M |
| Aug 24, 2026 | $127.47 | $128.36 | $126.31 | $127.98 | 799.61K |
Latest INCY news
The latest Smart Investors Daily articles mentioning INCY.
Stock researchCompany · Overview
INCY research
Overview
Company profile and research snapshot.
Company profile
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $98.88
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 20, 2026 | Canaccord Genuity | Buy | — |
| Aug 20, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 17, 2026 | Piper Sandler | Overweight | — |
| Aug 4, 2026 | Mizuho | Outperform | — |
| Aug 3, 2026 | Leerink Partners | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 18, 2026
Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals.
The S&P 500 and Nasdaq regain their 50-day lines and Treasury yields fall in a bullish day two Fed reaction. SpaceX, AMD, Moderna are buys.
ChartMill · Sep 18, 2026
Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum
INCY combines Minervini Trend Template strength, 93.53 RS, and high-growth momentum. Technical Rating 9, but watch resistance near 129.93 for breakout.
Yahoo · Sep 18, 2026
Dow Jones Futures Rise After Bullish S&P 500, Nasdaq Rebound; Moderna, AMD, SpaceX Flash Buy Signals
The S&P 500 and Nasdaq regain their 50-day lines and Treasury yields fall in a bullish day two Fed reaction. SpaceX, AMD, Moderna are buys.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
